Control of blood sugar and catching early signs of damage may help prevent advanced kidney disease and death….

Besides improving patients’ glucose numbers researchers saw improved metabolic features such as reductions in waist circumference….

We all know how hard it is to prescribe the right medication for a patient while not having it rejected for non-formulary or prior auth requirements, but do we ever think about how these insurance rules can lead to a disaster? This week we look at how a change of …

Last month, Richard Kahn, M.D., the former chief scientific officer for the American Diabetes Association, stated that even though weight loss can prevent or delay the onset of diabetes, these prevention programs are a “waste of resources” and the health system should focus instead on reducing the likelihood of complications …

Edited by Frank J. Snoek and T. Chas Skinner Diabetes in Older Adults   Microvascular complications The specific microvascular complications of diabetes may be less prominent in type 2 diabetes than in type 1 but they still provide cause for concern.

In this week’s Homerun Slides, Part 8 of Dr. Stanley Schwartz’s series on An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes, we continue with our discussion last week of the benefits of Ranolazine for diabetes patients….

For Dr. Kahn’s comments and the Joslin Diabetes Center’s response, see our article in last week’s newsletter: Joslin Replies to Dr. Richard Kahn’s Statement: “Diabetes Prevention is a Waste of Resources.”

Bydureon is now available in pharmacies. Medicare Update: The 28% cut in physician payments scheduled to begin March 1 will be postponed and/or will be offset by cuts in the budget.

  Telcare’s new iPhone App with 2 way cloud sync automatically synchronizes with a wireless glucose meter allowing patients and caregivers to see every glucose reading while tracking medication, nutrition, activities, and notes. The app also allows patients who don’t have the Telcare BGM to manually enter and track their …

Endocrinologists would prescribe a newly approved weekly treatment for Type 2 diabetes to one-fifth of their patients, a new survey showed. Decision Resources announced the results of a survey of US endocrinologists who said they would prescribe Bydureon to 20% of their patients taking into consideration the reimbursement hurdles and …